Sex and gender-oriented colorectal cancer screening: a consensus study from the AIOM- GISEG working group - Report - MDSpire

Sex and gender-oriented colorectal cancer screening: a consensus study from the AIOM- GISEG working group

  • By

  • Marta Bianchini

  • Tiziana Vavalà

  • Francesca Rossi

  • Elsa Vitale

  • Manuel Zorzi

  • Stefania Gori

  • Rossana Berardi

  • Anna Maria Moretti

  • Marialuisa Appetecchia

  • July 3, 2026

  • 0 min

Share

Clinical Report: Colorectal Cancer Screening Based on Sex and Gender

Overview

This consensus study identifies significant disparities in colorectal cancer (CRC) incidence and screening between men and women.

Background

Colorectal cancer is a leading cause of cancer-related mortality, with notable differences in incidence and outcomes based on sex and gender. Understanding these disparities is crucial for developing effective screening strategies.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • Disparities exist between men and women in CRC incidence, age at onset, and lesion distribution.
  • Participation rates in CRC screening differ by sex.
  • Expert consensus supports the collection of sex-disaggregated data in screening registries.
  • Communication strategies should address gender-specific barriers to screening adherence.
  • Optimal age and modality for CRC screening may differ between men and women.

Clinical Implications

Healthcare providers should consider sex and gender differences when recommending CRC screening strategies. Implementing tailored approaches may improve screening rates and outcomes for both men and women.

Conclusion

The findings from this consensus study underscore the importance of integrating sex and gender considerations into CRC screening practices to enhance patient care and outcomes.

Related Resources & Content

  1. Updates in Surgery, 2022 -- Gender Differences in Survival Rates and Long-Term Outcomes Following Colorectal Surgery
  2. Comparison of Clinical, Histopathological, Treatment, and Outcome Variables by Gender in 185,967 Patients with Colon Cancer, 2019
  3. The ASCO Post, 2021 -- Colorectal Cancer Screening: Preferences of Gastroenterologists and Primary Care Clinicians
  4. Recommendation: Colorectal Cancer: Screening | United States Preventive Services Taskforce
  5. Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex - PubMed
  6. Colorectal cancer statistics, 2026 - Siegel - 2026 - CA: A Cancer Journal for Clinicians
  7. The ASCO Post — Colorectal Cancer Screening: Preferences of Gastroenterologists and Primary Care Clinicians
  8. Recommendation: Colorectal Cancer: Screening | United States Preventive Services Taskforce
  9. Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex - PubMed
  10. Colorectal cancer statistics, 2026 - Siegel - 2026 - CA: A Cancer Journal for Clinicians - Wiley Online Library

Original Source(s)

Related Content